Abstract |
Mutations in the skeletal muscle voltage-gated sodium channel alpha-subunit gene (SCN4A) have been associated with a spectrum of inherited nondystrophic myotonias and periodic paralyses. Most disease-associated SCN4A alleles occur in portions of the gene that encode the third and fourth repeat domains with the conspicuous absence of mutations in domain 1. Here we describe a family segregating an unusual autosomal dominant congenital myotonia associated with debilitating pain especially severe in the intercostal muscles. A novel SCN4A mutation causing the replacement of Val445 in the sixth transmembrane segment of domain 1 with methionine was discovered in all affected individuals and is the likely genetic basis for the syndrome. Myotonia was resistant to treatment; however, the most severely affected family member responded dramatically to the sodium channel blocking agent flecainide.
|
Authors | J Rosenfeld, K Sloan-Brown, A L George Jr |
Journal | Annals of neurology
(Ann Neurol)
Vol. 42
Issue 5
Pg. 811-4
(Nov 1997)
ISSN: 0364-5134 [Print] United States |
PMID | 9392583
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Alleles
- DNA Mutational Analysis
- Exons
(genetics)
- Family Health
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Muscle, Skeletal
(chemistry, physiopathology)
- Myotonia Congenita
(complications, genetics)
- Pain
(etiology)
- Pedigree
- Phenotype
- Point Mutation
- Polymorphism, Single-Stranded Conformational
- Sodium Channels
(genetics)
|